AFB (TB) – Antibiogram for MTb Complex – Linezolid Drug by MGIT – Pure Growth of MTB Complex

This test measures the drug susceptibility of the Mycobacterium tuberculosis (MTb) complex, specifically for the Linezolid drug.

• This test is primarily done to identify if the bacteria are susceptible or resistant to Linezolid, ensuring the most effective treatment is administered. • Assessing the effectiveness of TB treatment • Identifying drug-resistant strains and adjusting treatment plans accordingly • Providing valuable information for infection control measures • Monitoring the emergence of drug resistance in communities

This test may be recommended if you • Have been diagnosed with TB and need to assess the efficacy of Linezolid treatment. • Show signs or symptoms of TB and need confirmation of diagnosis along with drug susceptibility testing. • Are at high risk for TB exposure or have been in close contact with individuals diagnosed with drug-resistant TB.

Abnormal results may indicate drug resistance, requiring alternative treatment options.

Please reach out to your healthcare provider for any specific requirements.

• AFB smear and culture: These tests help diagnose TB and identify the presence of acid-fast bacilli. • GeneXpert MTB/RIF assay: This molecular test detects TB bacteria and assesses resistance to Rifampicin, another common anti-TB drug. • Chest X-ray: This imaging test helps evaluate the extent of lung involvement in TB.

Linezolid drug susceptibility test for the MTb complex

Tuberculosis (TB) is an infectious disease caused by the MTb complex bacteria. It primarily affects the lungs but can also affect other organs. TB is a serious condition that requires prompt diagnosis and appropriate treatment to prevent its spread and complications.